Transaction Notification for GSK plc

2025-12-22SEC Filing 6-K (0001654954-25-014212)

This filing reports several transactions by Persons Disclosing Managerial/ Relevant information (PDMR) or persons closely associated with them (PCA) at GSK plc in December 2025. Wendy Becker, Independent Non-Executive Director, purchased 441 ordinary shares of GSK plc on December 19, 2025, on the London Stock Exchange for ÂŖ18.0909 per share. Elizabeth McKee Anderson, Independent Non-Executive Director, purchased 201 American Depositary Shares (ADSs) on December 19, 2025, on the New York Stock Exchange for $48.5550 per share. Charles Bancroft, Senior Independent Non-Executive Director, purchased 1,577 ADSs on December 19, 2025, on the New York Stock Exchange for $48.5550 per share. Dr. Anne Beal, Independent Non-Executive Director, purchased 201 ADSs on December 19, 2025, on the New York Stock Exchange for $48.5550 per share. Dr. Hal Dietz, Independent Non-Executive Director, purchased 201 ADSs on December 19, 2025, on the New York Stock Exchange for $48.5550 per share. Dr. Jeannie Lee, Independent Non-Executive Director, purchased 202 ADSs on December 19, 2025, on the New York Stock Exchange for $48.5550 per share. Dr. Vishal Sikka, Independent Non-Executive Director, purchased 730 ADSs on December 19, 2025, on the New York Stock Exchange for $48.5550 per share. Lady Susan Symonds, PCA of Sir Jonathan Symonds (Non-Executive Chair), purchased 1,650 ordinary shares on December 22, 2025, on the London Stock Exchange for ÂŖ18.1046 per share. All transactions were initial notifications.

Ticker mentioned:GSK